MMSL 2018, 87(2):61-67 | DOI: 10.31482/mmsl.2018.013

SURGICAL TREATMENT OF GASTRIC ADENOCARCINOMA: TOTAL VS. SUBTOTAL GASTRECTOMY. A SINGLE CENTRE EXPERIENCEOriginal article

Kateřina Vinklerová1, Radomír Hyšpler2, Jiří Páral ORCID...1,3, Petr Lochman ORCID...1,3*
1 Faculty of Military Health Sciences, University of Defence in Brno
2 Institute of Clinical Biochemistry and Diagnostics, University Hospital, Hradec Králové
3 Department of Surgery, University Hospital, Hradec Králové

The purpose of this study is to analyze postoperative morbidity and mortality of patients undergoing various types of gastric resection for adenocarcinoma in a single centre and to evaluate the oncological outcome regarding to completeness of resection.Ninety-eight patients with gastric adenocarcinoma were involved in the present study. We observed postoperative complications or death and a length of hospital stay, completeness of resection, TNM staging. Differences in overall survival between total (TG) and subtotal gastrectomy (SG) were analyzed using analysis of variance (ANOVA) and Kruskal-Wallis test with p < 0,05 value.There was no statistically significant difference in overall survival between both groups (p = 0,409). R0 vs. R1 resection could be evaluated in 72 patients with no difference in survival among them (p = 0,003). The median time to recurrence were 12 and 11 months in R0 and R1 resection, respectively. The median time of overall survival were 20 and 15,5 months in R0 and R1 patients, but without statistical significance (p = 0,406). The only statistical difference was found in the length of survival between T1 and T3 stage (p = 0,009).If R0 resection could be achieved, there was no difference in overall survival and time to recurrence between TG and SG.

Keywords: gastric adenocarcinoma; gastrectomy; overall survival

Received: October 14, 2017; Revised: March 19, 2018; Prepublished online: March 28, 2018; Published: June 8, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vinklerová, K., Hyšpler, R., Páral, J., & Lochman, P. (2018). SURGICAL TREATMENT OF GASTRIC ADENOCARCINOMA: TOTAL VS. SUBTOTAL GASTRECTOMY. A SINGLE CENTRE EXPERIENCE. MMSL, 87(2), 61-67. doi: 10.31482/mmsl.2018.013
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(8):S4-66. Go to original source... Go to PubMed...
    2. Available on http://www.who.int/mediacentre/factsheets/fs297/en/ , cited on 15 September 2017
    3. Available on http://www.svod.cz/ , cited on 15 September 2017
    4. Gorbunov EJ, Wechsler TS, Tomin A. Significant Prognostic Factors in 283 Patients After Surgery For Adenocarcinoma of the Stomach. Scripta Medica. 2005;78(1):3-16.
    5. Bozzetti F, Marubini E, Bonfanti G. Total versus Subtotal Gastrectomy: surgical morbidity and mortality rates in a multicentre Italian randomized trial. Annals of Surgery. 1997;226(5):614-615. Go to original source... Go to PubMed...
    6. Crew K, Neugut AI. Epidemiology of Gastric Cancer. World J. Gastroenterol. 2006;12(3):354-362. DOI: 10.3748/wjg.v12.i3.354. Go to original source... Go to PubMed...
    7. Nomura A, Schottenfeld D, Fraumeni JF. Cancer Epidemiology and Prevention. 2nd ed., Oxford University Press. 1996. 707-724.
    8. Wanebo HJ, Kennedy BJ, Chmiel J. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg. 1993;218:583-592. Go to original source... Go to PubMed...
    9. Gouzi JL, Huguier M, Fagniez PL, Launois B, Flamant Y, Lacaine F, Paquet JC, Hay JM. Total versus Subtotal Gastrectomy for Adenocarcinoma of the Gastric Antrum. A French prospective controlled study. Ann. Surg. 1989;209:162-166. Go to original source...
    10. Hermanek P, Wittekind C. Residual Tumor (R) Classification and Prognosis. Semin. Surg. Oncol. 1994;10:12-20. Go to original source... Go to PubMed...
    11. Abe S, Shiraishi MAI, Nagaoka S, Yoshimura H, Dhar DK, Nakamura T. Serosal Invasion as the Single Prognostic Indicator in Stage IIIA (T3N1M0). Gastric Cancer Surgery. 1991;109:582-588.
    12. Kwon SJ. Evaluation of the 7th UICC TNM staging system of gastric cancer. J Gastric Cancer. 2011;11(2):78-85. DOI: 10.5230/jgc.2011.11.2.78. Go to original source... Go to PubMed...
    13. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113-123. Go to original source... Go to PubMed...

    Return to the content